Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10487
Gene Symbol: CAP1
CAP1
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 9564
Gene Symbol: BCAR1
BCAR1
0.010 Biomarker disease BEFREE Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43). 31820288 2020
Entrez Id: 1483
Gene Symbol: CTAA1
CTAA1
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 1500
Gene Symbol: CTNND1
CTNND1
0.010 Biomarker disease BEFREE Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43). 31820288 2020
Entrez Id: 4012
Gene Symbol: LNPEP
LNPEP
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 100528016
Gene Symbol: TMX2-CTNND1
TMX2-CTNND1
0.010 Biomarker disease BEFREE Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43). 31820288 2020
Entrez Id: 9423
Gene Symbol: NTN1
NTN1
0.010 GeneticVariation disease BEFREE Now, a rapidly growing literature suggests that (1) these same alterations could occur in humans, and (2) genetic variants in Netrin-1 and DCC are associated with depression, schizophrenia, and substance use. 31659271 2020
Entrez Id: 1434
Gene Symbol: CSE1L
CSE1L
0.010 Biomarker disease BEFREE Specific significant associations included links between CAS and alcohol use (b = 0.40), childhood sexual abuse and unstable housing (b = - 0.75), alcohol use and childhood sexual abuse (b = 0.40), and substance use and intimate partner violence (b = 0.43). 31820288 2020
Entrez Id: 9200
Gene Symbol: HACD1
HACD1
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 6611
Gene Symbol: SMS
SMS
0.010 Biomarker disease BEFREE Within an RCT comparing ILM assessment/schedule methods, 162-participants completed daily IVR (n = 81) or SMS (n = 81) assessments measuring 19 substance use and violence (partner/non-partner) behaviors daily for 90-days. 31645000 2020
Entrez Id: 23476
Gene Symbol: BRD4
BRD4
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 10580
Gene Symbol: SORBS1
SORBS1
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 5269
Gene Symbol: SERPINB6
SERPINB6
0.010 GeneticVariation disease BEFREE The CAP Study: Evaluating a Comprehensive Universal and Targeted Intervention Designed to Prevent Substance Use and Related Harms in Australian Adolescents; http://www.anzctr.org.au/; ACTRN12612000026820. 31051243 2020
Entrez Id: 38
Gene Symbol: ACAT1
ACAT1
0.010 Biomarker disease BEFREE The data clearly show an increased prevalence of OUD, justifying the need for evidence-based substance use programs such as MAT in jail settings in the South. 31195879 2019
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.010 AlteredExpression disease BEFREE Baseline physical activity, substance use and plasma growth hormone are independent predictors of physical activity six months after an acute EBV infection in adolescents, whereas markers of the infection and associated immune response do not seem to be associated with physical activity six months later. 30685875 2019
Entrez Id: 151516
Gene Symbol: ASPRV1
ASPRV1
0.010 Biomarker disease BEFREE Screening uses validated measures (Tobacco, Alcohol, Prescription medication, and other Substance use [TAPS]; and the Adult Outcomes Questionnaire [AOQ], which includes the Patient Health Questionnaire [PHQ-9] and Generalized Anxiety Disorder [GAD-2]) delivered via three modalities (secure messaging, tablets in waiting rooms, and desktop computers in exam rooms). 31446142 2019
Entrez Id: 57120
Gene Symbol: GOPC
GOPC
0.010 GeneticVariation disease BEFREE Factor analyses supported general EXT and CAL factors; however, unique AD/DD overlapped highly with shared EXT, suggesting that DSM substance use symptoms in our study reflect more general problems with disconstraint/impulsivity rather than variance specific to substances. 31634490 2019
Entrez Id: 2195
Gene Symbol: FAT1
FAT1
0.010 GeneticVariation disease BEFREE Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy. 30657779 2019
Entrez Id: 54751
Gene Symbol: FBLIM1
FBLIM1
0.010 GeneticVariation disease BEFREE Factor analyses supported general EXT and CAL factors; however, unique AD/DD overlapped highly with shared EXT, suggesting that DSM substance use symptoms in our study reflect more general problems with disconstraint/impulsivity rather than variance specific to substances. 31634490 2019
Entrez Id: 2782
Gene Symbol: GNB1
GNB1
0.010 AlteredExpression disease BEFREE Genetic covariation of Gnb1 expression, preference for sensory stimuli and multiple ethanol phenotypes suggest that heritable variation in Gnb1 expression in reward circuitry partially underlies the widely reported relationship between sensation seeking and substance use. 30221471 2019
Entrez Id: 4143
Gene Symbol: MAT1A
MAT1A
0.010 Biomarker disease BEFREE The data clearly show an increased prevalence of OUD, justifying the need for evidence-based substance use programs such as MAT in jail settings in the South. 31195879 2019
Entrez Id: 1297
Gene Symbol: COL9A1
COL9A1
0.010 GeneticVariation disease BEFREE Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy. 30657779 2019
Entrez Id: 619538
Gene Symbol: OMS
OMS
0.010 GeneticVariation disease BEFREE 5,9% improvement in OMS-HC score, p < 0,05) and substance use problems (e.g. 31317439 2019
Entrez Id: 9709
Gene Symbol: HERPUD1
HERPUD1
0.010 Biomarker disease BEFREE A majority of the studies found lower QoL in PP-SUPs than in general population, with substance use by the person with a SUP having the most impact on QoL of all evaluated factors. 30453992 2018
Entrez Id: 7809
Gene Symbol: BSND
BSND
0.010 Biomarker disease BEFREE College students were administered self-report questionnaires (Zuckerman Sensation Seeking Scale [ZSS], Barratt Impulsiveness Scale [BIS-11], behavioral measures related to risk-taking and impulsivity (Balloon Analog Risk Task [BART], Experiential Discounting Task [EDT]), and the substance use module of a clinical interview (past-six-month alcohol and marijuana use). 29660594 2018